Original Article
Evaluation of eCura scoring system for treatment strategy selection after non-curative endoscopic resection of early gastric cancer
Fu Fengqin, Lin Xiaolu, Cheng Hui, Liang Wei, Deng Wanyin, Zhong Shishun, Zheng Jinhui, Jiang Sirui, Jiang Yuting, Zheng Xiaoling
Published 2022-01-20
Cite as Chin J Dig Endosc, 2022, 39(1): 53-59. DOI: 10.3760/cma.j.cn321463-20210224-00984
Abstract
ObjectiveTo evaluate the adjuvant role of the eCura scoring system in selecting appropriate treatment strategies after non-curative endoscopic submucosal dissection (ESD) of early gastric cancer (EGC) patients.
MethodsThe clinicopathological data of 110 EGC patients who underwent non-curative ESD at Fujian Provincial Hospital from January 2015 to June 2019 were retrospectively analyzed. According to the eCura score, patients were divided into three lymph node metastasis (LNM) risk groups: low-risk group (79 cases), middle-risk group (22 cases), and high-risk group (9 cases). The receiver operator characteristic (ROC) curve analysis was used to test the diagnostic efficacy of eCura scoring system in predicting LNM. Logistic regression analysis was used to explore the influence of risk stratification of eCura scoring system on LNM. Kaplan-Meier method was used to evaluate cancer survival rate, which was then compared with log-rank test.
ResultsThirty-five patients underwent additional standard surgery after ESD, including 22 in the low-risk group, 8 in the middle-risk group, and 5 in the high-risk group. Among them, 5 cases had LNM, including 1 case in the low-risk group and the middle-risk group respectively and 3 cases in the high-risk group. The area under the ROC curve was 0.857 (95%CI: 0.697-0.952, P=0.001), and when the cut-off value of the eCura score was set at 3, the Yuden index reached the maximum value of 0.7, with the corresponding sensitivity and specificity of 80% and 90%, respectively. Logistic regression analysis showed that the probability of LNM in the middle-risk group was about 3.00 times (95%CI: 0.17-54.57, P=0.458) as high as that in the low-risk group, and the probability of LNM in the high-risk group was about 31.50 times (95%CI: 2.14-463.14, P=0.012) of that in the low-risk group. The follow-up time was 12 to 58 months, and the median follow-up time was 40 months. There were 10 cases of recurrence, including 4 cases in the low-risk group, 3 cases in the middle-risk group and 3 cases in the high-risk group, of which 2 cases in the low-risk group were from those of additional standard surgery after ESD, and the remaining 8 cases were from those who did not receive additional standard surgery after ESD. Kaplan-Meier survival curve analysis showed that the survival rate of patients with additional surgery in the low-risk group was similar to that of patients without (P=0.319), and the survival rate of patients with additional surgery in the middle-risk group was also similar to that of patients without (P=0.296). The survival rate of patients with additional surgery in the high-risk group was significantly higher than that of those without (P=0.013).
ConclusionThe eCura scoring system can assist the selection of treatment strategies after non-curative resection of EGC, and can accurately predict the risk of subsequent LNM and recurrence. Close follow-up may be an acceptable option for patients with low risk of LNM, and additional standard surgical treatment may be more conducive to improving the prognosis in patients with high risk of LNM.
Key words:
Stomach neoplasms; Early gastric cancer; Endoscopic submucosal dissection; Non-curative resection; eCura scoring system
Contributor Information
Fu Fengqin
Provincial Clinical Medical College of Fujian Medical University, Fuzhou 350001, China
Digestive Endoscopy Center, Fujian Provincial Hospital, Fuzhou 350001,China
Lin Xiaolu
Digestive Endoscopy Center, Fujian Provincial Hospital, Fuzhou 350001,China
Cheng Hui
Department of Pathology, Fujian Provincial Hospital, Fuzhou 350001, China
Liang Wei
Digestive Endoscopy Center, Fujian Provincial Hospital, Fuzhou 350001,China
Deng Wanyin
Digestive Endoscopy Center, Fujian Provincial Hospital, Fuzhou 350001,China
Zhong Shishun
Digestive Endoscopy Center, Fujian Provincial Hospital, Fuzhou 350001,China
Zheng Jinhui
Digestive Endoscopy Center, Fujian Provincial Hospital, Fuzhou 350001,China
Jiang Sirui
Provincial Clinical Medical College of Fujian Medical University, Fuzhou 350001, China
Digestive Endoscopy Center, Fujian Provincial Hospital, Fuzhou 350001,China
Jiang Yuting
Provincial Clinical Medical College of Fujian Medical University, Fuzhou 350001, China
Digestive Endoscopy Center, Fujian Provincial Hospital, Fuzhou 350001,China
Zheng Xiaoling
Digestive Endoscopy Center, Fujian Provincial Hospital, Fuzhou 350001,China